Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1991
12/04/1991CN1056632A Apparatus preparing concentrate of coagulation factors, such as fibrinogen, from blood sample
12/03/1991US5070188 Acylated epidermal growth factor
12/03/1991US5069905 Method and compositions comprising a vitamin d derivatives for the local treatment of bone fractures
12/03/1991US5069904 Alzheimer's disease
12/03/1991US5069898 Hair enrichment composition and method of use
12/03/1991CA1292697C Transdermal administration of amines
12/03/1991CA1292694C Inhibition of interleukin-1 by monocytes and/or macrophages
12/02/1991WO1991018602A1 (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
12/02/1991CA2043341A1 Pharmaceutical compounds
12/01/1991CA2043468A1 Sulfur-containing heterocyclic compounds
12/01/1991CA2042159A1 Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
12/01/1991CA2041951A1 Method for preventing onset of restenosis after angioplasty employing pravastatin
11/1991
11/30/1991CA2043424A1 Azole derivatives
11/28/1991WO1991018098A1 Bone and cartilage inductive proteins
11/28/1991WO1991018013A1 Synthetic senescent cell antigen
11/28/1991WO1991017997A1 PROCESS FOR THE PREPARATION OF 7α-ALKOXYCEPHEM DERIVATIVES
11/28/1991WO1991017778A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample
11/28/1991WO1991017770A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991WO1991014437A3 Use of copper(ii) containing compounds to accelerate wound healing
11/28/1991WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
11/28/1991CA2083391A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991CA2083150A1 Synthetic senescent cell antigen
11/28/1991CA2082941A1 Bone and cartilage inductive proteins
11/27/1991EP0458661A1 Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments
11/27/1991EP0458640A2 Use of ergoline derivatives for the treatment of diseases associated with bone demineralization
11/27/1991EP0458636A1 Antiemetic and migraine suppressing heterocyclic compounds and pharmaceutical compositions containing them
11/27/1991EP0458590A1 Treatment of ocular hypertention with a synergistic combination
11/27/1991EP0458589A1 Treatment of ocular hypertension with an ocular synergistic combination
11/27/1991EP0458587A1 Synergistic combination for ophthalmic use
11/27/1991EP0458519A2 Synthesis of nucleotide and nucleoside derivatives
11/27/1991EP0458207A2 Indole derivatives
11/27/1991EP0458079A2 Ultrasonic contrast agent, its preparation and application as diagnostic or therapeutic
11/27/1991EP0458072A1 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
11/27/1991EP0458064A2 Stabilization of somatotropins and other proteins by modification of cysteine residues
11/27/1991EP0457950A1 Use of stearidonic acid in the treatment of inflammatory disorders
11/27/1991EP0457856A1 Isolation growth and differentiation of human muscle cells
11/27/1991EP0457803A1 4-hydroxythiazoles as 5-lipoxygenase inhibitors
11/27/1991CN1056499A Heterocyclic-nmda antagonists
11/27/1991CN1056496A Improvements in and relating to ergoline-8-carboxamides
11/27/1991CA2043216A1 Use of substituted .beta.-hydroxyethylamines as potent inhibitors of the exoenzymes of fungi
11/26/1991WO1991018888A1 N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders
11/26/1991US5068412 (2R,3S,4S)-α-(carboxycyclopropyl)glycine
11/26/1991US5068354 Cathepsin B inhibitors, enzyme inhibitors for muscular disorders
11/26/1991US5068351 Catalytic amidation in the presence of phosphinic anhydride, cyclization
11/26/1991US5068332 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
11/26/1991US5068314 Lipopolysaccharide-binding polypeptide
11/26/1991US5068251 Lipoxygenase inhibiting compounds
11/26/1991CA2083735A1 N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders
11/26/1991CA2042960A1 Method of inhibiting demineralization of bone
11/25/1991CA2042545A1 Synthesis of nucleotide and nucleoside derivatives
11/23/1991CA2042904A1 Oxidant sensitive and insensitive aromatic esters as inhibitors or human neutrophil elastase
11/22/1991WO1991017987A1 Phenol and pyridinol derivatives as pharmaceuticals
11/22/1991CA2081982A1 Phenol and pyridinol derivatives as pharmaceuticals
11/22/1991CA2042905A1 Indole derivatives
11/21/1991EP0457686A1 Novel aminopiperidine, aminopyrrolidine and aminoperhydroazepine derivatives, process for their preparation and pharmaceutical compositions containing them
11/21/1991EP0457514A1 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
11/21/1991EP0457324A1 Heterocyclic-NMDA antagonists
11/21/1991EP0457295A2 Use of a modulator of protein phosphorylation in the treatment of amyloidosis associated with Alzheimer's disease
11/21/1991EP0457163A1 Use of oxyl-aminoacid derivatives as drug for inhibiting the prolyl-hydroxylase
11/21/1991EP0456835A1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
11/21/1991EP0456760A1 Lipoxygenase inhibiting compounds
11/19/1991US5066801 Preparation of sulfonic acid esters
11/19/1991US5066676 Sulfonamido derivative inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them
11/19/1991US5066644 Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
11/19/1991US5066480 Treating pulmonary hypertension caused by protamine induced neutralization of heparin
11/19/1991US5066427 Eicosatriynoic acid esters and their application in pharmaceutical and cosmetic practice
11/19/1991CA2042875A1 Aminopiperidin, aminopyrrolidin and aminoperhydroazepin derivatives, their preparation process and pharmaceutical compositions containing them
11/19/1991CA1292343C Di- and tri-peptidal renin inhibitors
11/19/1991CA1292244C Hydroxamic acid derivatives and method of using same
11/19/1991CA1292239C Cycloalkyl-substituted 4-aminophenyl halo derivatives and process for their preparation
11/19/1991CA1292236C Process for preparing n-alkylated amino acids and esters thereof
11/19/1991CA1292235C Derivatives of 5-pentylamino-5-oxopentanoic and 4- pentylamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin and a method for their preparation
11/19/1991CA1292186C Rectally absorbable form of l-dopa
11/17/1991WO1991017989A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/17/1991CA2083040A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/16/1991CA2042437A1 Immunologic enhancement of the somatogenic effect of somatotrophin with an antibody
11/14/1991WO1991017249A1 Interleukin-1 antagonist and uses thereof
11/14/1991WO1991017174A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991WO1991017151A1 New pharmacologically active catechol derivatives
11/14/1991WO1991017146A1 Novel histamine h3-receptor agonist compounds for therapeutic use, pharmaceutical compositions acting as agonists of said receptor and method of preparation
11/14/1991WO1991015222A3 Method of predisposing mammals to accelerated tissue repair
11/14/1991WO1991011453A3 5-oxygenated-2,4,6-triaminopyrimidines
11/14/1991CA2374571A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991CA2081774A1 Interleukin-1 antagonist and uses thereof
11/13/1991EP0456332A1 Purified interleukin 1 and DNA coding for interleukin 1 and their preparation, vectors containing such DNA and their preparation and use in transforming hosts to permit expression of interleukin 1
11/13/1991EP0456214A1 Fluorinated derivatives of mevinic acids
11/13/1991EP0456209A2 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
11/13/1991EP0456188A1 Therapeutic agent for hepatocirrhosis
11/13/1991EP0456185A2 Renin inhibitors
11/13/1991EP0456133A1 Hydrazones
11/13/1991CA2042282A1 Oxalylamino acid derivatives, processes for their preparation and their use as medicaments for inhibiting proline hydroxylase
11/12/1991WO1991018100A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity
11/12/1991US5064851 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
11/12/1991US5064849 Heterocyclic derivatives useful as radiosensitizing agents and antiviral agents
11/12/1991US5064832 Biaryl compounds
11/12/1991US5064830 Lowering of blood uric acid levels
11/12/1991US5064819 Substituted propane-phosphinic acid compounds
11/12/1991US5064817 Phospholipase a2 inhibiting compositions and their use
11/12/1991US5064811 De-mannosyl teicoplanin derivatives
11/12/1991US5064810 Use of branched chain amino acids to effect diaphragm contractility and fatigue
1 ... 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 ... 1564